{"id":"NCT02118766","sponsor":"Pfizer","briefTitle":"Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis","officialTitle":"A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-03","primaryCompletion":"2015-04","completion":"2015-04","firstPosted":"2014-04-21","resultsPosted":"2017-03-06","lastUpdate":"2017-03-06"},"enrollment":763,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Dermatitis, Atopic"],"interventions":[{"type":"DRUG","name":"AN2728 Topical Ointment, 2%","otherNames":[]},{"type":"DRUG","name":"Matching vehicle control","otherNames":[]}],"arms":[{"label":"AN2728 Topical Ointment, 2%","type":"EXPERIMENTAL"},{"label":"Matching vehicle control","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to investigate the safety and efficacy of AN2728 Topical Ointment, 2% in children, adolescents, and adults (ages 2 years and older) with atopic dermatitis.","primaryOutcome":{"measure":"Percentage of Participants Who Achieved Treatment Success Based on Investigator's Static Global Assessment (ISGA) at Day 29","timeFrame":"Day 29","effectByArm":[{"arm":"AN2728 Topical Ointment, 2 Percent","deltaMin":32.8,"sd":null},{"arm":"AN2728 Topical Ointment, Vehicle","deltaMin":25.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.038"}]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":7},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["38206678","35292919","34379285","33728583","32574023","32318744","30345457","27417017"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":502},"commonTop":["Burning/Stinging: Mild","Burning/Stinging: Moderate","Burning/Stinging: Severe","Application site pain","Upper respiratory tract infection"]}}